Metraipolis › archive › dc_8ffd41bb05a7
Pharmacologic Treatment of Metabolic Dysfunction-Associated Steatotic Liver Disease in the Context of Type 2 Diabetes — Europe PMC PMID:41831086
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41831086
- DOI
- 10.1007/s11892-[numero omesso]-w
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-04T18:33:27.999Z
- SHA-256 of the archived text
d57245afbb184ba4e40c6b281907c3adde6152d27f521a582fa62f348f83d32c- Stable URL of this page
https://metraipolis.com/documento/dc_8ffd41bb05a7
How to cite
Pharmacologic Treatment of Metabolic Dysfunction-Associated Steatotic Liver Disease in the Context of Type 2 Diabetes — Europe PMC PMID:41831086 — Europe PMC (en), https://europepmc.org/article/MED/41831086 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_8ffd41bb05a7 (Metraipolis archive dc_8ffd41bb05a7, sha256 d57245afbb184ba4e40c6b281907c3adde6152d27f521a582fa62f348f83d32c)
BibTeX
@misc{dc8ffd41bb05a7,
title = {Pharmacologic Treatment of Metabolic Dysfunction-Associated Steatotic Liver Disease in the Context of Type 2 Diabetes — Europe PMC PMID:41831086},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41831086},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_8ffd41bb05a7; sha256 d57245afbb184ba4e40c6b281907c3adde6152d27f521a582fa62f348f83d32c},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41831086. Agents can read the archived copy with the MCP tool read_document.